Scarica l'app Stockscreener
4.36
7.23%
-0.34
Pre-mercato:
4.47
0.11
+2.52%
BiomX Inc Borsa (PHGE) Ultime notizie
H.C. Wainwright reiterates Buy rating on BiomX stock amid FDA queries By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy rating on BiomX stock amid FDA queries - Investing.com Canada
BiomX (NYSEAMERICAN:PHGE) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
HC Wainwright Issues Optimistic Estimate for BiomX Earnings - Defense World
BiomX (NYSEAMERICAN:PHGE) Price Target Raised to $26.00 at HC Wainwright - Defense World
HC Wainwright Issues Positive Forecast for BiomX (NYSEAMERICAN:PHGE) Stock Price - Defense World
HC Wainwright Boosts BiomX (NYSEAMERICAN:PHGE) Price Target to $26.00 - Defense World
HC Wainwright & Co. Reiterates BiomX (PHGE) Buy Recommendation - Nasdaq
Why Is BiomX Stock Falling Today?BiomX (AMEX:PHGE) - Benzinga
BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review - Sahm
PHGE: HC Wainwright & Co. Reiterates Buy Rating with $26 PT | PH - GuruFocus
BiomX To Continue Cystic Fibrosis Study With Revised Dosing Of BX004; Data Expected In Q2, 2026 - Nasdaq
BiomX Says Working to Lift FDA Hold Concerning Nebulizer Device in Phase 2b Study of BX004 for Cystic Fibrosis - MarketScreener
FDA Review Delays BiomX's (PHGE) Cystic Fibrosis Trial Progress - GuruFocus
BiomX Updates on Phase 2b Study for BX004 - TipRanks
BiomX provides update on BX004 Phase 2b trial in Cystic Fibrosis - TipRanks
BiomX Updates on FDA Clinical Hold and Study Progress - TradingView
BiomX (NYSE American: PHGE) DMC Backs BX004 Phase 2b Study, Topline Expected 2026 - Stock Titan
PHGE: HC Wainwright Raises Price Target for BiomX to $26.00 | PH - GuruFocus
HC Wainwright & Co. Maintains BiomX (PHGE) Buy Recommendation - Nasdaq
BiomX price target adjusted to $26 from $15 at H.C. Wainwright - TipRanks
Stock splits calendar for: - Yahoo Finance Singapore
BiomX announces FDA feedback on development pathway for BX011 - MSN
BiomX Inc. Reports Q3 2025 Financial Results and Program Updates - MSN
BiomX Inc. Earnings Call: Progress Amid Challenges - MSN
Why BiomX Inc. stock stays undervaluedJuly 2025 Trends & Precise Swing Trade Entry Alerts - newser.com
BiomX Stock to Reverse Split on Tuesday, November 25th (NYSEAMERICAN:PHGE) - Defense World
BiomX Stock to Reverse Split on Tuesday, November 25th (NYSEMKT:PHGE) - Defense World
BiomX Inc. COmmon Stock (NYSE:PHGE) Stock Quote - Markets Financial Content
Can BiomX Inc. stock retain market dominanceEarnings Recap Summary & Low Volatility Stock Recommendations - newser.com
Why BiomX Inc. stock could see breakout soonIndex Update & Proven Capital Preservation Methods - newser.com
Will BiomX Inc. stock see PE expansionJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
Will BiomX Inc. stock extend growth storyPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Is BiomX Inc. stock a momentum leader2025 Buyback Activity & Daily Profit Focused Screening - newser.com
BiomX Inc. (PHGE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will BiomX Inc. stock attract long term capital inflowsFed Meeting & Safe Capital Investment Plans - newser.com
Will BiomX Inc. stock rise with strong economyJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Forecasting BiomX Inc. price range with options dataJobs Report & AI Forecast Swing Trade Picks - newser.com
0.45%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):